Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients

Published:2020-12-15 Issue:5 Volume:25 Page:575-585
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Akizawa Tadao¹,Yamaguchi Yusuke²,Majikawa Yoshikatsu³,Reusch Michael⁴

Affiliation:

1. Division of Nephrology, Department of Medicine Showa University School of Medicine Tokyo Japan

2. Data Science, Development Astellas Pharma, Inc. Tokyo Japan

3. Japan‐Asia Clinical Development 2, Development Astellas Pharma, Inc. Tokyo Japan

4. Development Medical Science Astellas Pharma Europe B.V. Tokyo Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13609

Reference21 articles.

1. Mechanisms of Anemia in CKD

2. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

3. An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease

4. Erythropoiesis-stimulating agent hyporesponsiveness (Review Article)

5. Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Anemia Associated with Chronic Kidney Disease: Plea for Considering Physiological Erythropoiesis;International Journal of Molecular Sciences;2024-07-03

2. Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studies;Clinical and Experimental Nephrology;2024-03-26

3. Clinical effect of roxadustat vs. erythropoietin in non-dialysis CKD with diabetes: a single center propensity score matching analysis;International Urology and Nephrology;2024-03-15

4. Impact of C-reactive protein on the effect of Roxadustat for the treatment of anemia in chronic kidney disease: a systematic review of randomized controlled trials;BMC Nephrology;2024-02-05

5. Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease;Journal of Clinical Medicine;2023-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3